Anne Thomas

13.8k total citations · 3 hit papers
222 papers, 7.6k citations indexed

About

Anne Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anne Thomas has authored 222 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 45 papers in Molecular Biology. Recurrent topics in Anne Thomas's work include Colorectal Cancer Treatments and Studies (38 papers), Cancer Genomics and Diagnostics (22 papers) and Cancer Treatment and Pharmacology (21 papers). Anne Thomas is often cited by papers focused on Colorectal Cancer Treatments and Studies (38 papers), Cancer Genomics and Diagnostics (22 papers) and Cancer Treatment and Pharmacology (21 papers). Anne Thomas collaborates with scholars based in United Kingdom, United States and Belgium. Anne Thomas's co-authors include Edward A. Boyse, K Yamazaki, Judith Bard, William P. Steward, M. Arny, H E Broxmeyer, English D, Sandra K. Cooper, Lynne Howells and Bruno Morgan and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Anne Thomas

210 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

1989 844 citations Anne Thomas et al. profile →
Control of mating preferences in mice by genes in the major histocompatibility complex.

1976 502 citations Anne Thomas et al. profile →
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

2014 339 citations Timothy Price, Marc Peeters et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Thomas United Kingdom	43	2.0k	1.9k	1.1k	965	754	222	7.6k
A. Veerman Netherlands	64	3.1k 1.5×	2.1k 1.1×	897 0.8×	1.1k 1.2×	3.0k 4.0×	302	11.6k
Olfert Landt Germany	43	3.1k 1.5×	1.2k 0.7×	305 0.3×	709 0.7×	484 0.6×	141	8.1k
Toshihiro Nakajima Japan	42	4.3k 2.1×	1.3k 0.7×	296 0.3×	2.3k 2.4×	355 0.5×	149	8.5k
Kazuo Takahashi Japan	50	2.4k 1.2×	538 0.3×	501 0.4×	1.6k 1.6×	412 0.5×	311	8.1k
Takafumi Ishida Japan	44	2.5k 1.2×	723 0.4×	492 0.4×	1.2k 1.2×	149 0.2×	317	7.7k
M. Bishr Omary United States	75	8.1k 4.0×	1.5k 0.8×	990 0.9×	1.6k 1.7×	362 0.5×	259	17.1k
Philip I. Murray United Kingdom	54	2.0k 1.0×	2.2k 1.2×	1.0k 0.9×	1.3k 1.4×	382 0.5×	262	9.4k
Robert S. Fulton United States	38	4.7k 2.4×	692 0.4×	378 0.3×	692 0.7×	1.4k 1.8×	85	7.9k
Peter A. Horn Germany	40	3.0k 1.5×	818 0.4×	269 0.2×	2.1k 2.2×	593 0.8×	260	7.1k
Michael Bergmann Austria	43	2.0k 1.0×	1.3k 0.7×	543 0.5×	1.3k 1.4×	297 0.4×	268	6.8k

Countries citing papers authored by Anne Thomas

Since Specialization

Citations

This map shows the geographic impact of Anne Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Thomas more than expected).

Fields of papers citing papers by Anne Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Thomas. The network helps show where Anne Thomas may publish in the future.

Co-authorship network of co-authors of Anne Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Thomas. A scholar is included among the top collaborators of Anne Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Thomas. Anne Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Howells, Lynne, et al.. (2025). Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance. Cancer Investigation. 43(2). 119–140. 1 indexed citations

Coyle, Vicky M., Richard Adams, Ashley Agus, et al.. (2024). Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health Technology Assessment. 28(14). 1–101. 1 indexed citations

Thomas, Anne, et al.. (2024). Retropharyngeal Abscess Complicated by Mediastinitis in Infants. Respiration. 103(10). 651–659. 2 indexed citations

Paul, Christine, Nicole M. Verrills, Stephen P. Ackland, et al.. (2024). The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology. BMC Health Services Research. 24(1). 320–320.

Yang, Phillip, et al.. (2023). Dialectical Behavior Therapy in Juvenile Correctional and Detention Facilities: A Scoping Review. Journal of Correctional Health Care. 29(5). 355–369. 4 indexed citations

Howells, Lynne, et al.. (2022). The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis. British Journal of Cancer. 128(2). 297–309. 38 indexed citations

Guterman, Inna, Kevin West, Hong Cai, et al.. (2022). Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells. PLoS ONE. 17(2). e0262364–e0262364. 17 indexed citations

Howells, Lynne, et al.. (2021). A Systematic Review Assessing Clinical Utility of Curcumin with a Focus on Cancer Prevention. Molecular Nutrition & Food Research. 65(13). e2000977–e2000977. 20 indexed citations

Puranik, Ameya, et al.. (2021). Myeloid Sarcoma of the Prostatic Tissue Diagnosed on 18F-FDG PET/CT in Treated Case of Acute Myeloid Leukemia. Indian Journal of Nuclear Medicine. 36(2). 193–194. 1 indexed citations

10.

Thomas, Anne, Neha Mittal, Swapnil Rane, et al.. (2021). Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center. Head and Neck Pathology. 15(4). 1137–1146. 12 indexed citations

11.

Howells, Lynne, Chinenye Iwuji, Shaun Barber, et al.. (2019). Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. Journal of Nutrition. 149(7). 1133–1139. 181 indexed citations

12.

Kim, Tae Won, Marc Peeters, Anne Thomas, et al.. (2018). Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer. Clinical Cancer Research. 24(22). 5602–5609. 41 indexed citations

13.

Peeters, Marc, Timothy Price, Michael Boedigheimer, et al.. (2018). Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study. Clinical Cancer Research. 25(4). 1216–1225. 32 indexed citations

14.

Verma, Ajay, Daniel Fernández-García, Panchali Sarmah, et al.. (2018). Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity. Cell Death and Disease. 9(9). 894–894. 38 indexed citations

15.

Wood, Jeffrey & Anne Thomas. (2016). Assessing the Clinical Impact of Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine Monotherapy. 1(2).

16.

Thomas, Anne, et al.. (2016). Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Clinical Nutrition. 36(1). 65–78. 64 indexed citations

17.

Rodón, Jordi, Hussein Tawbi, Anne Thomas, et al.. (2014). A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors. Clinical Cancer Research. 20(7). 1900–1909. 187 indexed citations

18.

Palm, Melanie D., et al.. (2007). Differential Anti-Influenza Activity among Allelic Variants at The Sus Scrofa Mx1 Locus. Journal of Interferon & Cytokine Research. 27(2). 147–156. 24 indexed citations

19.

Galldiks, Norbert, Lutz Kracht, Lothar Burghaus, et al.. (2006). Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 516–524. 89 indexed citations

20.

Thomas, Anne, Jacques Mainil, & Annick Lindén. (2003). Mycoplasma bovis: synthèse des connaissances actuelles. Annales de médecine vétérinaire. 147(1). 23–39. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact